1. Home
  2. EML vs ANIX Comparison

EML vs ANIX Comparison

Compare EML & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastern Company (The)

EML

Eastern Company (The)

N/A

Current Price

$25.55

Market Cap

152.9M

ML Signal

N/A

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

N/A

Current Price

$3.71

Market Cap

119.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EML
ANIX
Founded
1858
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
152.9M
119.8M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
EML
ANIX
Price
$25.55
$3.71
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.67
AVG Volume (30 Days)
9.0K
194.0K
Earning Date
05-12-2026
05-27-2026
Dividend Yield
1.98%
N/A
EPS Growth
185.40
12.82
EPS
1.04
N/A
Revenue
$248,970,345.00
$210,000.00
Revenue This Year
$19.05
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$24.63
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.61
$2.32
52 Week High
$29.91
$5.46

Technical Indicators

Market Signals
Indicator
EML
ANIX
Relative Strength Index (RSI) N/A 63.08
Support Level N/A $2.73
Resistance Level N/A $3.89
Average True Range (ATR) 0.00 0.18
MACD 0.00 0.03
Stochastic Oscillator 0.00 97.18

Price Performance

Historical Comparison
EML
ANIX

About EML Eastern Company (The)

The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to the industrial market. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It has one reportable segment: Engineered Solutions, which provides engineered solutions mainly for the commercial transportation and logistics markets. This segment offers a diverse product line of custom and standard vehicular and industrial hardware, including turnkey returnable packaging solutions, blow molds, compression latches, draw latches, hinges, camlocksaccess, mirrors, and mirror-cameras, among other products. Geographically, the group derives maximum revenue from the United States.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: